Testing a surgery plan for low-risk uterine cancer recurrence prevention
Part of Cancer, Women’s health & pregnancy clinical trials.
This trial looks at preventing the cancer from coming back after treatment for very low-risk endometrial (uterine) cancer. It studies a surgery approach that avoids removing lymph nodes, using scans and blood testing to choose the right patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 19 or older
- Your cancer type is endometrioid (a specific subtype of uterine cancer)
- Your doctors plan surgery that does not include lymph node removal in the pelvis
- Your MRI of the pelvis and CA-125 blood test fit the trial’s low-risk criteria
- There is no spread of cancer to distant parts of the body
- You have not had any uterine cancer treatment before, and you have not had a hysterectomy before
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at better ways to predict how aggressive your endometrial cancer is before surgery, so doctors can decide if they need to check your lymph nodes. It may help tailor your treatment to avoid unnecessary procedures.
This study compares two ways to check lymph nodes during surgery for early-stage endometrial (uterine) cancer: sentinel node biopsy versus removing more lymph nodes. It may help find whether the less extensive approach can stage the cancer accurately with fewer side effects.
This trial compares two ways to remove lymph nodes during hysterectomy for endometrial cancer that hasn't spread. The goal is to find which method works better with similar or fewer side effects.
This trial tests whether removing only the first lymph node to detect cancer spread (sentinel node mapping) is as effective as removing all lymph nodes in the pelvic area (comprehensive lymphadenectomy) for a specific type of endometrial cancer with a p53 mutation, stages I–II. The goal is to see if the less extensive surgery can result in similar outcomes while possibly reducing side effects.
This trial studies whether removing an early, hormone-responsive uterine growth using a procedure through the cervix can keep fertility possible. It is for people under 40 with a specific low-risk uterine biopsy and MRI findings who have already tried hormone treatment.
This is a research study that looks at outcomes in women with endometrial (uterine) cancer who receive the usual standard surgery. Researchers will group patients based on the final surgical and pathology results and what additional (if any) treatment is recommended afterward.
Hear when a new Endometrial Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.